Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lindsey Hendrickson"'
Autor:
James A. Davis, PharmD, BCOP, Abigail Shockley, PharmD, Amanda Herbst, PA-C, Lindsey Hendrickson, DNP, APRN, FNP-C
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 14:67-72
Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressive non-Hodgkin lymphoma in the US. For nearly 2 decades, standard front-line treatment has consisted of chemoimmunotherapy with rituximab, cyclophosphamide, doxorubicin, vincris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f52c0c847ed5a4958fab6c022ffc34c
https://doi.org/10.6004/jadpro.2023.14.1.6
https://doi.org/10.6004/jadpro.2023.14.1.6
Autor:
Lindsey Hendrickson, Iya Znoyko, James Kalmuk, Daynna J. Wolff, Irl Brian Greenwell, Zane Chiad, Cynthia A. Schandl, Sandra Mazzoni, Nina D. Wagner-Johnston, Brian T. Hess
Publikováno v:
Cancer Genetics. :18-22
Richter transformation (RT) refers to the development of an aggressive lymphoma in patients with pre-existing chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). It carries a poor prognosis secondary to poor response to therapy or rapi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a170bec3590538e5ba0754e467c66eaf
https://doi.org/10.1016/j.cancergen.2021.10.003
https://doi.org/10.1016/j.cancergen.2021.10.003
Autor:
James A. Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J. Gaffney, Mary McGann, Alyssa Cendagorta, Aswani Thurlapati, Amanda Herbst, Lindsey Hendrickson, Hamza Hashmi, Brian T. Hess
Publikováno v:
Blood.
COVID-19 still represents a major issue for patients with lymphoid malignancies, especially those on therapy, because of immune suppression and suboptimal responses to vaccination. Davis et al report on their experience with double dose tixagevimab-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c9658555999e1f1c67e4a7310763dc
https://pubmed.ncbi.nlm.nih.gov/36332185
https://pubmed.ncbi.nlm.nih.gov/36332185
Autor:
James A. Davis, Jagoda Misniakiewicz, Lindsey Hendrickson, Mary McGann, Amanda Herbst, Brian T. Hess
Publikováno v:
Annals of hematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dfbc4ea5db5e26286d68ce731fc68ab
https://pubmed.ncbi.nlm.nih.gov/36385650
https://pubmed.ncbi.nlm.nih.gov/36385650
Publikováno v:
Leukemia & Lymphoma. 63:2016-2018
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67ee32d60ea0f7e0cc24e3110c8255ad
https://doi.org/10.1080/10428194.2022.2056179
https://doi.org/10.1080/10428194.2022.2056179
Publikováno v:
Leukemialymphoma. 63(8)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::190f050351c311b9f4808d3af95d4dec
https://pubmed.ncbi.nlm.nih.gov/35341452
https://pubmed.ncbi.nlm.nih.gov/35341452
Autor:
Fang Hu, Brian T. Hess, Sarah Hogan, Nina D. Wagner-Johnston, Lindsey Hendrickson, Shanta Salzer, Leandro Cerchietti, Robin Klingenberg, Elizabeth G. Hill, Lacey Finch, Anshu Giri
Publikováno v:
Blood. 138:3567-3567
Background A significant portion of diffuse large B-cell lymphoma (DLBCL) patients (35-40%) relapse or are refractory to frontline chemotherapy. The standard of care for relapsed/refractory (R/R) DLBCL patients has been salvage chemotherapy followed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::523dd4073fcbd95fd057c54ba75357a7
https://doi.org/10.1182/blood-2021-145493
https://doi.org/10.1182/blood-2021-145493
Autor:
James Kalmuk, Lindsey Hendrickson, Cynthia A. Schandl, Zane Chiad, Brian T. Hess, Sandra Mazzoni, Iya Znoyko, Irl Brian Greenwell, Daynna J. Wolff
Publikováno v:
Blood. 134:1736-1736
Background: Richter Transformation (RT) is defined as the transformation of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) into an aggressive lymphoma. Diffuse large B-cell lymphoma (DLBCL) makes up the vast majority of RT and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::488a45183b5f5dae17b726c63eccc7e3
https://doi.org/10.1182/blood-2019-124514
https://doi.org/10.1182/blood-2019-124514